Genetics of rheumatoid arthritis: Underlying evidence of ethnic differences

Journal of Autoimmunity

Volumn 32, Issue 3-4, 2009, Pages 158-162

  Kochi, Yuta ^a   Suzuki, Akari ^a   Yamada, Ryo ^a,b   Yamamoto, Kazuhiko ^a,c  

^a RIKEN   (Japan)

^b THE UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Ethnic difference; Genetic predisposition; Genome wide association study; Rheumatoid arthritis

Indexed keywords

CD16 ANTIGEN; HLA DR ANTIGEN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22;

ASIAN; CD244 GENE; ETHNIC DIFFERENCE; EUROPE; FCRL3 GENE; GENE; GENE FREQUENCY; GENE MAPPING; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOME ANALYSIS; HUMAN; PADI4 GENE; POPULATION GENETICS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ANTIGENS, CD; ARTHRITIS, RHEUMATOID; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HLA-DR ANTIGENS; HUMANS; HYDROLASES; POLYMORPHISM, GENETIC; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; RECEPTORS, IMMUNOLOGIC;

EID: 67349228199     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2009.02.020     Document Type: Review

References (70)

1. Abdel-Nasser A.M., Rasker J.J., and Valkenburg H.A. Epidemiological and clinical aspects relating to the variability of rheumatoid arthritis. Semin Arthritis Rheum 27 (1997) 123-140
2. Alamanos Y., and Drosos A.A. Epidemiology of adult rheumatoid arthritis. Autoimmun Rev 4 (2005) 130-136
3. MacGregor A.J., Snieder H., Rigby A.S., Koskenvuo M., Kaprio J., Aho K., et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 43 (2000) 30-37
4. Seldin M.F., Amos C.I., Ward R., and Gregersen P.K. The genetics revolution and the assault on rheumatoid arthritis. Arthritis Rheum 42 (1999) 1071-1079
5. Deighton C.M., Walker D.J., Griffiths I.D., and Roberts D.F. The contribution of HLA to rheumatoid arthritis. Clin Genet 36 (1989) 178-182
6. Begovich A.B., Carlton V.E., Honigberg L.A., Schrodi S.J., Chokkalingam A.P., Alexander H.C., et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 75 (2004) 330-337
7. Plenge R.M., Padyukov L., Remmers E.F., Purcell S., Lee A.T., Karlson, et al. Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. Am J Hum Genet 77 (2005) 1044-1060
8. Lee Y.H., Rho Y.H., Choi S.J., Ji J.D., Song G.G., Nath S.K., et al. The PTPN22 C1858T functional polymorphism and autoimmune diseases-a meta-analysis. Rheumatology (Oxford) 46 (2007) 49-56
9. Suzuki A., Yamada R., Chang X., Tokuhiro S., Sawada T., Suzuki M., et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 34 (2003) 395-402
10. Ikari K., Kuwahara M., Nakamura T., Momohara S., Hara M., Yamanaka H., et al. Association between PADI4 and rheumatoid arthritis: a replication study. Arthritis Rheum 52 (2005) 3054-3057
11. Kang C.P., Lee H.S., Ju H., Cho H., Kang C., and Bae S.C. A functional haplotype of the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Koreans. Arthritis Rheum 54 (2006) 90-96
12. Kochi Y., Yamada R., Suzuki A., Harley J.B., Shirasawa S., Sawada T., et al. A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat Genet 37 (2005) 478-485
13. Suzuki A., Yamada R., Kochi Y., Sawada T., Okada Y., Matsuda K., et al. Functional SNPs in CD244 increase the risk of rheumatoid arthritis in a Japanese population. Nat Genet 40 (2008) 1224-1229
14. Fernando, M.M., Stevens, C.R., Walsh, E.C., De Jager, P.L., Goyette, P., Plenge, R.M., et al. 2008. Defining the role of the MHC in autoimmunity: a review and pooled analysis. PLoS Genet 4: e1000024.
15. Newton J.L., Harney S.M., Wordsworth B.P., and Brown M.A. A review of the MHC genetics of rheumatoid arthritis. Genes Immun 5 (2004) 151-157
16. Gregersen P.K., Silver J., and Winchester R.J. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 30 (1987) 1205-1213
17. du Montcel S.T., Michou L., Petit-Teixeira E., Osorio J., Lemaire I., Lasbleiz S., et al. New classification of HLA-DRB1 alleles supports the shared epitope hypothesis of rheumatoid arthritis susceptibility. Arthritis Rheum 52 (2005) 1063-1068
18. de Vries N., Tijssen H., van Riel P.L., and van de Putte L.B. Reshaping the shared epitope hypothesis: HLA-associated risk for rheumatoid arthritis is encoded by amino acid substitutions at positions 67-74 of the HLA-DRB1 molecule. Arthritis Rheum 46 (2002) 921-928
19. Mattey D.L., Dawes P.T., Gonzalez-Gay M.A., Garcia-Porrua C., Thomson W., Hajeer A.H., et al. HLA-DRB1 alleles encoding an aspartic acid at position 70 protect against development of rheumatoid arthritis. J Rheumatol 28 (2001) 232-239
20. Morgan A.W., Haroon-Rashid L., Martin S.G., Gooi H.C., Worthington J., Thomson W., et al. The shared epitope hypothesis in rheumatoid arthritis: evaluation of alternative classification criteria in a large UK Caucasian cohort. Arthritis Rheum 58 (2008) 1275-1283
21. Kochi Y., Yamada R., Kobayashi K., Takahashi A., Suzuki A., Sekine A., et al. Analysis of single-nucleotide polymorphisms in Japanese rheumatoid arthritis patients shows additional susceptibility markers besides the classic shared epitope susceptibility sequences. Arthritis Rheum 50 (2004) 63-71
22. Lee H.S., Lee K.W., Song G.G., Kim H.A., Kim S.Y., and Bae S.C. Increased susceptibility to rheumatoid arthritis in Koreans heterozygous for HLA-DRB1*0405 and *0901. Arthritis Rheum 50 (2004) 3468-3475
23. Kong K.F., Yeap S.S., Chow S.K., and Phipps M.E. HLA-DRB1 genes and susceptibility to rheumatoid arthritis in three ethnic groups from Malaysia. Autoimmunity 35 (2002) 235-239
24. Wakitani S., Imoto K., Murata N., Toda Y., Ogawa R., and Ochi T. The homozygote of HLA-DRB1*0901, not its heterozygote, is associated with rheumatoid arthritis in Japanese. Scand J Rheumatol 27 (1998) 381-382
25. Klareskog L., Ronnelid J., Lundberg K., Padyukov L., and Alfredsson L. Immunity to citrullinated proteins in rheumatoid arthritis. Annu Rev Immunol 26 (2008) 651-675
26. Irigoyen P., Lee A.T., Wener M.H., Li W., Kern M., Batliwalla F., et al. Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles. Arthritis Rheum 52 (2005) 3813-3818
27. Furuya T., Hakoda M., Ichikawa N., Higami K., Nanke Y., Yago T., et al. Differential association of HLA-DRB1 alleles in Japanese patients with early rheumatoid arthritis in relationship to autoantibodies to cyclic citrullinated peptide. Clin Exp Rheumatol 25 (2007) 219-224
28. Verpoort K.N., van Gaalen F.A., van der Helm-van Mil A.H., Schreuder G.M., Breedveld F.C., Huizinga T.W., et al. Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis. Arthritis Rheum 52 (2005) 3058-3062
29. Hill J.A., Southwood S., Sette A., Jevnikar A.M., Bell D.A., and Cairns E. Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol 171 (2003) 538-541
30. Frazer K.A., Ballinger D.G., Cox D.R., Hinds D.A., Stuve L.L., Gibbs R.A., et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 449 (2007) 851-861
31. Burton P.R., Clayton D.G., Cardon L.R., Craddock N., Deloukas P., Duncanson A., et al. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447 (2007) 661-678
32. Plenge R.M., Cotsapas C., Davies L., Price A.L., de Bakker P.I., Maller J., et al. Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat Genet 39 (2007) 1477-1482
33. Plenge R.M., Seielstad M., Padyukov L., Lee A.T., Remmers E.F., Ding B., et al. TRAF1-C5 as a risk locus for rheumatoid arthritis-a genomewide study. N Engl J Med 357 (2007) 1199-1209
34. Julia A., Ballina J., Canete J.D., Balsa A., Tornero-Molina J., Naranjo A., et al. Genome-wide association study of rheumatoid arthritis in the Spanish population: KLF12 as a risk locus for rheumatoid arthritis susceptibility. Arthritis Rheum 58 (2008) 2275-2286
35. Coenen M.J., and Gregersen P.K. Rheumatoid arthritis: a view of the current genetic landscape. Genes Immun 10 2 (2009) 101-111 Epub 2008 Nov 6
36. Bowes J., and Barton A. Recent advances in the genetics of RA susceptibility. Rheumatology (Oxford) 47 (2008) 399-402
37. Kurreeman, F.A., Padyukov, L., Marques, R.B., Schrodi, S.J., Seddighzadeh, M., Stoeken-Rijsbergen, G., et al. 2007. A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis. PLoS Med 4: e278.
38. Thomson W., Barton A., Ke X., Eyre S., Hinks A., Bowes J., et al. Rheumatoid arthritis association at 6q23. Nat Genet 39 (2007) 1431-1433
39. Remmers E.F., Plenge R.M., Lee A.T., Graham R.R., Hom G., Behrens T.W., et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 357 (2007) 977-986
40. Raychaudhuri S., Remmers E.F., Lee A.T., Hackett R., Guiducci C., Burtt N.P., et al. Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat Genet 40 (2008) 1216-1223
41. Mori M., Yamada R., Kobayashi K., Kawaida R., and Yamamoto K. Ethnic differences in allele frequency of autoimmune-disease-associated SNPs. J Hum Genet 50 (2005) 264-266
42. Lee Y.H., Rho Y.H., Choi S.J., Ji J.D., and Song G.G. PADI4 polymorphisms and rheumatoid arthritis susceptibility: a meta-analysis. Rheumatol Int 27 (2007) 827-833
43. Kallberg H., Padyukov L., Plenge R.M., Ronnelid J., Gregersen P.K., van der Helm-van Mil A.H., et al. Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis. Am J Hum Genet 80 (2007) 867-875
44. Del Rincon I., Battafarano D.F., Arroyo R.A., Murphy F.T., Fischbach M., and Escalante A. Ethnic variation in the clinical manifestations of rheumatoid arthritis: role of HLA-DRB1 alleles. Arthritis Rheum 49 (2003) 200-208
45. Klareskog L., Stolt P., Lundberg K., Kallberg H., Bengtsson C., Grunewald J., et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 54 (2006) 38-46
46. Lee H.S., Irigoyen P., Kern M., Lee A., Batliwalla F., Khalili H., et al. Interaction between smoking, the shared epitope, and anti-cyclic citrullinated peptide: a mixed picture in three large North American rheumatoid arthritis cohorts. Arthritis Rheum 56 (2007) 1745-1753
47. Mei L., Li X., Yang K., Cui J., Fang B., Guo X., et al. Evaluating gene x gene and gene x smoking interaction in rheumatoid arthritis using candidate genes in GAW15. BMC Proc 1 Suppl 1 (2007) S17
48. Davis R.S. Fc receptor-like molecules. Annu Rev Immunol 25 (2007) 525-560
49. Marrack P., Kappler J., and Kotzin B.L. Autoimmune disease: why and where it occurs. Nat Med 7 (2001) 899-905
50. Ikari K., Momohara S., Nakamura T., Hara M., Yamanaka H., Tomatsu T., et al. Supportive evidence for a genetic association of the FCRL3 promoter polymorphism with rheumatoid arthritis. Ann Rheum Dis 65 (2006) 671-673
51. Hu X., Chang M., Saiki R.K., Cargill M.A., Begovich A.B., Ardlie K.G., et al. The functional -169T→C single-nucleotide polymorphism in FCRL3 is not associated with rheumatoid arthritis in white North Americans. Arthritis Rheum 54 (2006) 1022-1025
52. Martinez A., Sanchez E., Valdivia A., Orozco G., Lopez-Nevot M.A., Pascual-Salcedo D., et al. Epistatic interaction between FCRL3 and NFkappaB1 genes in Spanish patients with rheumatoid arthritis. Ann Rheum Dis 65 (2006) 1188-1191
53. Newman W.G., Zhang Q., Liu X., Walker E., Ternan H., Owen J., et al. Rheumatoid arthritis association with the FCRL3 -169C polymorphism is restricted to PTPN22 1858T-homozygous individuals in a Canadian population. Arthritis Rheum 54 (2006) 3820-3827
54. Thabet M.M., Wesoly J., Slagboom P.E., Toes R.E., and Huizinga T.W. FCRL3 promoter 169 CC homozygosity is associated with susceptibility to rheumatoid arthritis in Dutch Caucasians. Ann Rheum Dis 66 6 (2007) 803-806 Epub 2006 Dec 19
55. Begovich A.B., Chang M., and Schrodi S.J. Meta-analysis evidence of a differential risk of the FCRL3 -169T→C polymorphism in white and East Asian rheumatoid arthritis patients. Arthritis Rheum 56 (2007) 3168-3171
56. Simmonds M.J., Heward J.M., Carr-Smith J., Foxall H., Franklyn J.A., and Gough S.C. Contribution of single nucleotide polymorphisms within FCRL3 and MAP3K7IP2 to the pathogenesis of Graves' disease. J Clin Endocrinol Metab 91 (2006) 1056-1061
57. Owen C.J., Kelly H., Eden J.A., Merriman M.E., Pearce S.H., and Merriman T.R. Analysis of the Fc receptor-like-3 (FCRL3) locus in Caucasians with autoimmune disorders suggests a complex pattern of disease association. J Clin Endocrinol Metab 92 (2007) 1106-1111
58. Burton P.R., Clayton D.G., Cardon L.R., Craddock N., Deloukas P., Duncanson A., et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 39 (2007) 1329-1337
59. Weetman A.P. Autoimmune thyroid disease. Autoimmunity 37 (2004) 337-340
60. Umemura T., Ota M., Hamano H., Katsuyama Y., Kiyosawa K., and Kawa S. Genetic association of Fc receptor-like 3 polymorphisms with autoimmune pancreatitis in Japanese patients. Gut 55 (2006) 1367-1368
61. Shimada M., Onizuka M., Machida S., Suzuki R., Kojima M., Miyamura K., et al. Association of autoimmune disease-related gene polymorphisms with chronic graft-versus-host disease. Br J Haematol 139 (2007) 458-463
62. Matesanz F., Fernandez O., Milne R.L., Fedetz M., Leyva L., Guerrero M., et al. The high producer variant of the Fc-receptor like-3 (FCRL3) gene is involved in protection against multiple sclerosis. J Neuroimmunol 195 (2008) 146-150
63. Martinez A., Mas A., de Las Heras V., Bartolome M., Arroyo R., Fernandez-Arquero M., et al. FcRL3 and multiple sclerosis pathogenesis: role in autoimmunity?. J Neuroimmunol 189 (2007) 132-136
64. Umemura T., Ota M., Yoshizawa K., Katsuyama Y., Ichijo T., Tanaka E., et al. Lack of association between FCRL3 and FcgammaRII polymorphisms in Japanese type 1 autoimmune hepatitis. Clin Immunol 122 3 (2007) 338-342 Epub 2006 Oct 3
65. Turunen J.A., Wessman M., Kilpikari R., Parkkonen M., Forsblom C., and Groop P.H. The functional variant -169C/T in the FCRL3 gene does not increase susceptibility to Type 1 diabetes. Diabet Med 23 (2006) 925-927
66. Bhat R., Eissmann P., Endt J., Hoffmann S., and Watzl C. Fine-tuning of immune responses by SLAM-related receptors. J Leukoc Biol 79 (2006) 417-424
67. Nakajima H., Cella M., Langen H., Friedlein A., and Colonna M. Activating interactions in human NK cell recognition: the role of 2B4-CD48. Eur J Immunol 29 (1999) 1676-1683
68. Chlewicki L.K., Velikovsky C.A., Balakrishnan V., Mariuzza R.A., and Kumar V. Molecular basis of the dual functions of 2B4 (CD244). J Immunol 180 (2008) 8159-8167
69. Kumar K.R., Li L., Yan M., Bhaskarabhatla M., Mobley A.B., Nguyen C., et al. Regulation of B cell tolerance by the lupus susceptibility gene Ly108. Science 312 (2006) 1665-1669
70. Graham D.S., Vyse T.J., Fortin P.R., Montpetit A., Cai Y.C., Lim S., et al. Association of LY9 in UK and Canadian SLE families. Genes Immun 9 (2008) 93-102